Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study

Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease that occurs more frequently in children but can also manifest in adults. Approximately 15–20% of children are affected worldwide. Persistent AD may be present in approximately 50% of patients during childhood. Despite the pivo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariele Morandin Lopes, Ana Paula Moschione Castro, Túlio Morandin Ferrisse, Jorge Kalil, Ariana Campos Yang, Fabio Morato Castro
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2025-06-01
Series:Drugs in Context
Subjects:
atopic dermatitis
skin diseases
data collection
weights and measures
Online Access:https://www.drugsincontext.com/efficacy-and-safety-of-dupilumab-in-the-treatment-of-moderate-to-severe-atopic-dermatitis-a-real-life-study/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.drugsincontext.com/efficacy-and-safety-of-dupilumab-in-the-treatment-of-moderate-to-severe-atopic-dermatitis-a-real-life-study/

Similar Items